Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 430

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

British Association of Dermatologists' guidelines for the management of cutaneous warts 2014

Open access
Sterling, J.C., Gibbs, S., Haque Hussain, S.S., Mohd Mustapa, M.F., Handfield‐Jones, S.E., Hughes, J.R., Griffiths, M., McDonagh, A.J., Punjabi, S., Buckley, D.A., Nasr, I., Swale, V.J., Duarte Williamson, C.E., McHenry, P.M., Levell, N.J., Leslie, T., Mallon, E., Towers, K., Davis, R., Saunders, C., Brian, A.G., Exton, L.S. · 2014 · British Journal of Dermatology

Abstract

The overall objective of the guideline is to provide up‐to‐date, evidence‐based recommendations for the management of infectious cutaneous warts caused by papillomavirus infection. The document aims to (i) offer an appraisal of all relevant literature since January 1999, focusing on any key developments; (ii) address important practical clinical questions relating to the primary guideline objective, i.e. accurate diagnosis and identification of cases and suitable treatment; (iii) provide guideline recommendations, where appropriate with some health economic implications; and (iv) discuss potential developments and future directions. The guideline is presented as a detailed review with highlighted recommendations for practical use in the clinic, in addition to an updated patient information leaflet [available on the British Association of Dermatologists' (BAD) website, www.bad.org.uk]. This guideline does not cover anogenital warts, bowenoid papulosis, focal epithelial hyperplasia or seborrhoeic keratoses (sometimes called seborrhoeic warts). The guideline development group consisted of consultant and specialty trainee dermatologists and an editor of the Cochrane Skin Group. The draft document was circulated to the BAD membership, British Dermatological Nursing Group, Primary Care Dermatological Society, British Kidney Patients Association and Royal Pharmaceutical Society for comments, and was peer reviewed by the Clinical Standards Unit of the BAD (made up of the Therapy & Guidelines subcommittee) prior to publication. This set of guidelines has been developed using the BAD's recommended methodology,1 with reference to the Appraisal of Guidelines Research and Evaluation (AGREE II) instrument (www.agreetrust.org).2 Recommendations were developed for implementation in the National Health Service using a process of considered judgement based on the evidence. PubMed and the Medline and Embase databases were searched for meta‐analyses, randomized controlled trials (RCTs) and non‐RCTs, case series, case reports and open studies involving warts, published in the English language from January 1999 to March 2014; search terms and strategies are detailed in the Supporting Information. The Allied and Complementary Medicine Database was also searched for ‘warts’ with the same time restriction. Additional relevant references were also isolated from citations in the reviewed literature. Each author screened their set of identified titles, and those relevant for first‐round inclusion were selected for further scrutiny. Working in pairs, the authors then reviewed the abstracts for the shortlisted references, and the full papers of relevant material were obtained; disagreements in the final selections were resolved by discussion among the entire development group. The structure of the 2001 guidelines was then discussed and re‐evaluated, with headings and subheadings decided; different coauthors were allocated separate subsections. Each coauthor then performed a detailed appraisal of the selected literature, and all subsections were subsequently collated and edited to produce the final guideline. This document has been prepared on behalf of the BAD and is based on the best data available when the document was prepared. It is recognized that under certain conditions it may be necessary to deviate from the guidelines and that the results of future studies may require some of the recommendations herein to be changed. Failure to adhere to these guidelines should not necessarily be considered negligent, nor should adherence to these recommendations constitute a defence against a claim of negligence. The proposed revision for this set of recommendations is scheduled for 2019; where necessary, important interim changes will be updated on the BAD website. Warts are caused by infection of keratinocytes (the predominant cell type in the epidermis) by human papillomavirus (HPV). The development of epidermal thickening and hyperkeratinization occurs following infection at the basal layer and clonal proliferation, which eventually results in a visible wart, weeks or even months later. There are over 150 genotypically different types of HPV, with classification based on defined variation of the viral DNA. The majority of common warts are caused by HPV types 1, 2, 4, 27 or 57, and plane warts by HPV types 3 or 10. The HPV types originally identified in epidermodysplasia verruciformis (EV) and their closely related genotypes are also found on the skin, often as subclinical infections, but they can be associated with squamous cell cancer and premalignant dysplasias, especially in cases of immunosuppression. The term ‘warts’ includes all morphological varieties of warts and may sometimes be used to name wart‐like lesions, such as seborrhoeic keratoses or seborrhoeic ‘warts’, which are not caused by HPV infection. In this guideline the term ‘warts’ deals only with warts due to HPV infection. HPV‐associated warts are subdivided on anatomical or

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjd.13310

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 430

Metadata

Authors
Sterling, J. C., Gibbs, S., Haque Hussain, S. S., Mohd Mustapa, M. F., Handfield‐Jones, S. E., Hughes, J. R., Griffiths, M., McDonagh, A. J., Punjabi, S., Buckley, D. A., Nasr, I., Swale, V. J., Duarte Williamson, C. E., McHenry, P. M., Levell, N. J., Leslie, T., Mallon, E., Towers, K., Davis, R., Saunders, C., Brian, A. G., & Exton, L. S.
Venue
British Journal of Dermatology
Published
2014-10
Volume
171
Issue
4
Pages
696-712
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W2064820967
Cited by
430
References
31
FWCI
18.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. https://app.cochat.ai/papers/10.1111/bjd.13310
The paper
Sterling, J. C., Gibbs, S., Haque Hussain, S. S., Mohd Mustapa, M. F., Handfield‐Jones, S. E., Hughes, J. R., Griffiths, M., McDonagh, A. J., Punjabi, S., Buckley, D. A., Nasr, I., Swale, V. J., Duarte Williamson, C. E., McHenry, P. M., Levell, N. J., Leslie, T., Mallon, E., Towers, K., Davis, R., . . . Exton, L. S. (2014). British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. British Journal of Dermatology. https://doi.org/10.1111/bjd.13310

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.